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Abstract
This study investigates endocytosis and ER export signals of the yeast !-factor
receptor and the role that receptor oligomerization plays in these processes.  The !-factor
receptor contains signal sequences in the cytoplasmic C-terminal domain that are
essential for ligand-mediated endocytosis.  In an endocytosis complementation assay, I
found that oligomeric complexes of the receptor undergo ligand-mediated endocytosis
when the !-factor binding site and the endocytosis signal sequences are located in
different receptors. Both in vitro and in vivo assays strongly suggested that
ligand-induced conformational changes in one Ste2 subunit do not affect neighboring
subunits.  Therefore, the recognition of endocytosis signal sequence and the recognition
of the ligand-induced conformational change are likely to be two independent events,
where the signal sequence plays only a passive role in the ligand-induced endocytosis.
Four amino acid substitutions (C59R, H94P, S141P and S145P) in TM domains I, II and
III were identified that resulted in the accumulation of truncated receptors in the ER but
did not block ER export of full-length receptors.  The two DXE motifs in the C-terminal
tail were required for export of the mutant receptors from the ER; however DXE was not
essential for proper cell surface expression of wild-type receptors apparently because the
receptors contain redundant ER export signals.  An assay for oligomerization of receptors
in the ER was developed based on the ability of truncated mutant receptors to exit the
ER.  The four substitutions (C59R, H94P, S141P and S145P) that caused DXE-dependent
ER export failed to form homo-oligomers, suggesting that the DXE motifs and receptor
voligomerization serve as independent ER export signals.  Consistent with this view, two
of the substitutions (S141P and S145P), when coexpressed, with wild-type receptors,
formed hetero-oligomers that exited the ER.  Finally, the full-length oligomer-defective
mutant Ste2-S141P was sensitive to !-factor, suggesting that receptor monomers that
reach the cell surface are able to activate the heterotrimeric G protein.  The potential roles
that TM1, 2 and 3 play in receptor oligomerization are discussed.
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et al., 1996), dopamine  receptor  (Ng  et al., 1996; George  et al., 2000), opioid  receptor 
(Cvejic  and  Devi,  1997;  Jordan  and  Devi,  1999),  Ca2+­sensing  receptor  (Bai  et  al., 
1998), GABA receptor (Jones et al., 1998; White et al., 1998), M3 muscarinic receptor 
(Zeng  and Wess,  1999),  vasopressin  receptors  (Zhu  and Wess,  1998;  Terrillon  et  al., 
2004),  ­factor  receptor  (Overton  and  Blumer,  2000;  Yesilaltay  and  Jenness,  2000), 
somatotatin  receptor  (Rocheville  et  al.,  2000),  leukotriene B4  receptor BLT1  (Baneres 
  4 
and  Parello,  2003),  alpha2c­adrenergic  receptor  (Prinster  et  al.,  2006)  and  neurotensin 
receptor (White et al., 2007).  Evidence for dimerization of GPCRs is based on the results 
of  co­immunoprecipitation  analysis,  western  blot  analysis  and  the  bioluminescence 
resonance  energy  transfer  (BRET)  and  fluorescence  resonance  energy  transfer  (FRET) 
techniques.  The BRET and FRET have been employed to identify interactions between 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































forced A mixture (3.4 mM dATP, 200  M dTTP, 200  M dCTP, 200  M dGTP), forced 
T mixture (200  M dATP, 3.4 mM dTTP, 200  M dCTP, 200  M dGTP), forced C 
mixture (200  M dATP, 200  M dTTP, 3.4 mM dCTP, 200  M dGTP) and forced G 






































































































































































































































































































































































































































Ste2 forms expressed b  ­factor  n≥1  n≥3 
Ste2­F204S and Ste2­F204S­T326­GFP  ­  3±2  0 
Ste2­F204S and Ste2­F204S­T326­GFP  +  5±3  0 
Ste2 and Ste2­F204S­T326­GFP  ­  4±3  1±1 
Ste2 and Ste2­F204S­T326­GFP  +  77±5  16±6 
Ste2 and Ste2­T326­GFP  ­  5±4  1±1 
Ste2 and Ste2­T326­GFP  +  85±5  18±5 
Ste2­F204S and Ste2­T326­GFP  ­  4±2  1±1 






























































































































































































































































































































































































































































1.08 0.07  2.06 1.42 
Ste2­F204S 
 
























































































































































































































































In contrast to my results, complexes of the G protein coupled receptor BLT1 have 
been shown to undergo cross-conformational changes induced by agonist binding.  
Damien et al (2008) produced heterodimeric receptor complexes with wild-type BLT1 
and a BLT1/ALXR chimera, where the BLT1 subunit is activated by the BLT4 ligand 
and the BLT1/ALXR chimera is activated by ALXR agonists. They detected a 
BLT4-induced conformational changes in BLT1/ALXR as increased fluorescence of sole 
tryptophanyl residue located in the sixth transmembrane domain of the chimeric subunit.  
Despite the cross-conformational change, BLT4 was unable to promote G-protein 
coupling to the chimeric subunit when the coupling defective mutant receptor (BLTi3-1) 











































































































































































































































ER retention mutant screening Complementation mutant screening 



















































Subcloning  Subcloning 
F igure 4-1.  Two strategies for ER trafficking mutant screening.  PCR-based 
mutagenesis of the plasmid encoding Ste2-T326-GFP is depicted at the top.  The 
ER retention mutant screening method is shown on the left.  The complementation 
mutant screening method is shown on the right.  In this method ste2∆ cells contain 





























































































(A)           (B)           (C) 
     
(D)          (E)             (F) 
     
(G)          (H)             (I) 
     



























































































































































































































































































































































































































































































































   









   
   
   
























































































   






















   
   









   
   
   




















   






















   






















   
   
   









   
   
   









   
   
   
   




























































URA3 Vector        Ste2­F204S­T326­HA 
Ste2­T326­GFP      Ste2­S141P­T326­GFP 












































































































































































































































































































































































































       
     
 






































       
     
 
       


























































































































































































































A large body of evidence suggests that GPCRs form oligomers before reaching 
the cell surface.  A study of the serotonin 5-HT2C receptor has provided direct evidence 
for oligomer formation by using a microscopic technique that measures FRET 
efficiencies and indicates that the receptors form homodimers/oligomers in the ER 
(Herrick-Davis et al., 2006).  These types of observations raise the possibility that 
oligomerization plays a role in correct trafficking of GPCRs.  The best example involves 
GABA receptors.  GABAb R1 is retained in ER when expressed alone, and it is targeted 
to the cell surface when it forms dimers with GABAb R2 thereby masking an ER 
retention signal (Jones et al., 1998; White et al., 1998).  This result indicates that 
heterodimerization is required for GABA receptor trafficking to the cell surface.  In 
addition, the efficient plasma membrane trafficking of -1Dadrenergic requires co-
expression of -adrenergic receptors (Uberti et al., 2005).  In some cases, receptor 
interactions can have a negative impact on receptor trafficking as well.  For example, a 
mutant form of V2 vasopressin receptor that is retained in the ER associates with 
wild-type receptors and prevents the complexes from reaching the cell surface (Zhu and 
Wess, 1998; Morello et al., 2001).  Similarly, mutant forms of the -adrenergic receptor 
  156 
also prevent cell surface targeting of the wild-type -adrenergic receptor, and defects in a 
putative dimerization motif (GxxxGxxxL) in TM6 reduce cell surface expression 
(Salahpour et al., 2004).   
In the previous chapter, my results indicate that at least two independent signals 
promote ER export of the Ste2 protein.  One signal is in the C-terminal tail.  The other 
signal is in the heptahelical domain of the receptor.  My results from ER retention mutant 
screening and complementation mutant screening suggested that dimerizaton of Ste2p is 
necessary for Ste2p in an ER quality checkpoint control.  Previously, only the first 
transmembrane domain in the Ste2 receptor has been implicated in functioning as a 
dimerizaton interface since transmembrane I self-associates based on FRET assay 
(Overton et al., 2003).  Further investigation indicated that disruption of 56GxxxG60 motif 




This chapter describes an in vivo assay to address the issue of whether mutant 
receptors form homodimers with themselves or heterodimers with wild-type receptors.  
With this assay, I tested whether oligomerization of Ste2 accounts for the ER export 
signal that resides in the heptahelical domain of the receptor.  The basis of my assay rests 
on the assumption that full-length Ste2 can promote ER export of mutant truncated Ste2 
marked with GFP if and only if the two receptors form a complex.  The approach was 
applied to the ste2 mutants, described in Chapter 4, affecting transmembrane helices I, II 
and III.  Cells expressing both truncated Ste2-T326-GFP and full-length wild-type Ste2 
served as a positive control for the formation of homo-oligomers.  As noted previously 
(Yesilaltay and Jenness, 2000), Ste2-T326-GFP that would otherwise accumulate in the 
ER (see Fig. 4-14) escapes to the cell surface in cells that express full length Ste2.  For 
cells expressing Ste2-G56L-T326-GFP together with full length wild-type Ste2, the Ste2-
G56L-T326-GFP fluorescence accululated in the vacuole instead of the ER (compare Fig. 
5-1 with Fig. 4-14), indicating that Ste2-G56L-T326-GFP also form hetero-oligomers 
with the wild-type receptors.  This results at least qualitatively, contradicts the published 
work (Overton et al., 2003); however, as discussed below, it is possible that oligomers 
are disrupted only when both potential binding partners are mutant.  In contrast, for cells 
expressing either Ste2-C59R-T326-GFP or Ste2-H94P-T326-GFP together with 
























































































































(compare Fig. 5-1 with Fig. 4-14), suggesting that both mutants fail to form 
hetero-oligomers.  Results for the two mutants identified in the complementation 
screening strategy are depicted in Fig. 5-2.  For cells expressing either 
Ste2-S141P-T326-GFP or Ste2-S145P-T326-GFP together with full-length wild-type 
Ste2, the fluorescent mutant receptors accumulated at the cell surface instead of the ER 
(compare Fig. 5-2 with Fig. 4-12), indicating the formation of hetero-oligomers.  The 
result is consistent with my previous complementation test (Chapter 4) indicating that the 
Ste2-S141P-T326-GFP receptors promote -factor sensitivity when they are permitted to 
interact with Ste2-S184R receptors.   
I considered the possibility that the Ste2-H94P-T326-GFP receptor forms 
heterooligomer with the wild-type receptor and that the complexes are retained in the ER 
because the mutant receptor exerts a dominant negative effect on the exit of the 
hetero-oligomeric complex from the ER.  A reciprocal experiment was designed in which 
the wild-type full-length Ste2 was tagged with GFP and the truncated mutant receptor 
was expressed under the direction of the GPD promoter.  If hetero-oligomeric complexes 
were to form and were to be retained in the ER, then Ste2-GFP fluorescence would 
accumulate in the perinuclear location.  Ste2-GFP progressed to the vacuole when 
expressed alone (Fig. 5-3 top panel).  Ste2-H94-GFP progressed to the vacuole when 
expressed alone (Fig. 5-3 2nd panel).  In the reciprocal experiment, for cells expressing 
full-length Ste2-GFP together with truncated Ste2-H94P-T326, the full-length Ste2-GFP 
accumulates in the vacuole indicating that Ste2-H94P-T326 does not cause dominant 
retention of receptor complexes. (Fig. 5-3, 3rd from top two panels).  In the negative 
  160 
control experiment, for cells expressing full-length Ste2-H94P-GFP together with 
truncated Ste2-H94P-T326, the full-length Ste2-H94P-GFP accumulates in the vacuole 
(Fig. 5-3 buttom panel).   I conclude that Ste2-H94P-T326 does not exhibit a dominant 
retention phenotype, consistent with failure of the mutant receptor to form 



























































































































































































































































































































































































































































(compare Fig. 5-2 and Fig. 5-5). 
In order to summarize results from Chapters 4 and 5 in a more quantified format, I 
counted the cells that showed specific localization patterns and tabulated the results.  
Independent experiments representing each of the different Ste2 mutant combinations 
were performed at least three times, and over 100 cells were evaluated for each 
experiment.  Each of the cells in a microscopic field was assigned to one of five 
localization patterns depicted in Fig. 5-6.  For the localization pattern designated ER (Fig. 
5-6A), the cells show a fluorescent perinuclear ring and weaker fluorescence near the cell 
surface, reflecting the cortical ER.  I cannot exclude the possibility that a small amount of 
plasma membrane localization is also present.  For the vacuole pattern (Fig. 5-6B), the 
fluorescence accumulates in one or more round filled structures.  When examined, each 
of these structures coincided with a structure that was visible in the Nomarski image.  
Some of the cells (especially the wild-type Ste2-GFP cells) that were scored as the 
vacuole pattern also showed very faint fluorescence at the cell surface.  The localization 
pattern, designated Vac+ER (Fig. 5-6C), was a mixture of the vacuole and the ER pattern.  
For the PM pattern (Fig. 5-6D), the cell surface was visible with no perinulear 
fluorescence and little or no vacuolar fluorescence.  In the PM+ER pattern (Fig. 5-6E), 
the cell surface was brighter than the perinuclear ring.   
Table 5-1 shows the results from cells expressing truncated receptors alone (see Fig. 
4-14).  The bulk of the truncated wild-type receptors (Ste2-T326-GFP) accumulated at 
the cell surface, and two-thirds of the cells showed some ER staining as well, consistent 












































F igure 5-6.  Scoring method for the tabulated results in Tables 6-1,2 3 and 4.  (A) 
endoplasmic reticulum (ER)  (B) vacuole (Vac).  (C) ER+ Vac  (D) plasma membrane 










Ste2­T326­GFP  ­  ­  ­  66 2  34 2 
Ste2­G56L­T326­GFP  6 2  17 2  78 2  ­  ­ 
Ste2­C59R­T326­GFP  100  ­  ­  ­  ­ 
Ste2­H94P­T326­GFP  100  ­  ­  ­  ­ 
Ste2­S141P­T326­GFP  100  ­  ­  ­  ­ 











For cells expressing the truncated mutant receptors, Ste2-C59R-T326-GFP, 




Table 5-2 shows the localization results for the full-length mutant receptors.  For 
the wild-type Ste2-GFP, the bulk of the GFP fluorescence accumulated in the vacuole 
due to endocytosis of the full-length protein (Li et al., 1999).  Unlike the truncated 
mutant receptors (Table 5-1), the full-length mutant receptors exited the ER to varying 
efficiencies.  Nearly 100% of the Ste2-G56L-GFP and Ste2-H94P-GFP exited the ER and 
accumulated in the vacuole.  Ste2-C59R, Ste2-S141P and Ste2-S145P exited the ER at a 
reduced efficiency.  These results indicate that the C-terminal domain plays a significant 
role in promoting the export of wild-type and mutant receptors from the ER.   
Table 5-3 summarizes the results obtained with cells expressing GFP-tagged 
truncated receptors together with overproduced wild-type Ste2.  In comparing Table 5-3 
with Table 5-1, the results demonstrate that both Ste2-C59R-T326-GFP and 
Ste2-H94P-T326-GFP fail to form heterodimers with full-length wild-type Ste2 since all 
of GFP was retained in the ER.  In contrast, the Ste2-S141P-T326-GFP and 
Ste2-S145P-T326-GFP mutant receptors form heterodimers with wild-type Ste2, based 
on the shift in GFP signal the from ER (Table 5-1) to the plasma membrane and the 




Full­length Ste2  ER (%)  Vacuole (%)  ER+Vac (%)  PM (%) 
Ste2  ­  100  ­  ­ 
Ste2­G56L  ­  99 1  ­  1 1 
Ste2­C59R  36 3  21 4  43 6  ­ 
Ste2­H94P  1 1  97 2  2 2  ­ 
Ste2­S141P  20 1  53 3  27 2  ­ 













ER (%)  Vacuole (%)  ER+Vac (%)  PM (%) 
Ste2­HA / Ste2­T326­GFP  ­  19 3  ­  81 3 
Ste2­HA / G56L­T326­GFP  2 2  83 2  15 3  ­ 
Ste2­HA / C59R­T326­GFP  100  ­  ­  ­ 
Ste2­HA / H94P­T326­GFP  99 1  ­  1 1  ­ 
Ste2­HA / S141P­T326­GFP  ­  23 5  1 1  76 4 














(Fig. 5-1) in that, for over 80% of the cells, all of the truncated Ste2-G56L-T326-GFP 
exited ER, suggesting that most but not all of the Ste2-G56L-T326-GFP mutant receptors 
form heterdimers with wild­type Ste2.   
Table 5-4 summarizes the localization pattern of GFP-tagged truncated mutants, 
when they are co-expressed with full-length receptors containing the same amino acid 
substitution.  As expected, the Ste2-C59R-T326-GFP and Ste2-H94P-T326-GFP 
receptors were retained in the ER, consistent with the results in Table 5-3.  Interesting, 
the truncated Ste2-S141P-T326-GFP and Ste2-S145P-T326-GFP were also retained 
completely in the ER (Table 5-4), indicating both mutants failed to form homodimers 
even though they formed heterodimers efficiently (Table 5-3).  Ste2-G56L-T326-GFP 
showed a similar localization pattern in Table 5-3 and Table 5-4, indicating that 
Ste2-G56L-T326-GFP forms both homo-oligomers and hetero-oligomers.  These results 
appear to be inconsistent with the findings of Overton et al. (2003), who found that the 
Ste2-G56L substitution resulted in only a baseline level of oligomerization as judged by 
their FRET assay.   
Both Ste2-C59R and Ste2-H94P were substitution that may severely disrupt 
receptor structure.  The Ste2-C59R mutation replaces a small side chain with in a large 
and positively charged side chain, and the H94P substitute is expected cause in a kink in 
the TM2 helix.  I constructed additional mutants that causes less sevre effect, Ste2-C59A 
and Ste2-H94A, to test whether the original phenotypes depended on the presence of 






ER (%)  Vacuole (%)  ER+Vac (%)  PM (%) 
Ste2­HA / Ste2­T326­GFP  ­  22 4  ­  78 4 
G56L­HA / G56L­T326­GFP  5 2  77 6  18 7  ­ 
C59R­HA / C59R­T326­GFP  100  ­  ­  ­ 
H94P­HA / H94P­T326­GFP  100  ­  ­  ­ 
S141P­HA / S141P­T326­GFP  99 1  1 1  ­  ­ 





















































































       
































































In this chapter, oligomerization of Ste2 in the ER was analyzed using an in vivo 
assay devised to address whether the two classes of mutants identified in Chapter 4 can 
form hetero-oligomers or homo-oligomers.  As the basis of the assay, I tested whether 
GFP-tagged mutant receptors that are retained in the ER can be exported when co-
expressed with untagged proteins that exit the ER.  The data obtained from fluorescence 
microscopic images were quantified by counting single cells representing different 
phenotypic groups.  The results suggest that Ste2-C59R and Ste2-H94P fail to form 
homooligomers or hetero-oligomers in the ER, that Ste2-G56L is partially defective for 
homooligomer and heterodimer formation, and that Ste2-S141P and Ste2-S145P fail to 
form homo-oligomers even though they form hetero-oligomers with wild-type receptors.  
I considered the possibility that the failure of GFP-tagged truncated mutants to be rescued 
by full-length receptors was due to a dominant-negative effect of the truncated receptors 
on ER exit and not due to failure to form oligomers.  The inability of the overexpressed 
Ste2-H94P-T326 to retain the full-length wild-type Ste2-GFP or full-length mutant 
Ste2-H94P-GFP in the ER is inconsistent with this hypothesis.  Results from Chapter 4 
suggest that independent signals for ER export are located in the C-terminal tail of the 
receptor and in the heptahelical domain.  From the Chapter 5 results, it is clear that the 
signal(s) in the C-terminal tail do not require oligomerization, whereas the failure of the 
mutants affecting the heptahelical domain are consistent with the hypothesis that 
oligomerization provides the second ER export signal.  
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Overall, my results indicate that TM domains I (containing Cys59), II (containing 
His94) and III (containing Ser141 and Ser145), are important for receptor 
oligomerization as well as for ER export.  One possibility for the failure to form 
oligomeric complexes is that the mutant receptors are grossly unfolded.  This does not 
appear to be the case for Ste2-S141P and Ste2-S145P since they are capable of 
recognizing and associating with wild-type full-length receptors.  Moreover, the 
full-length Ste2-S141P receptors that escape the ER are functional, and Ste2-S141-T326 
forms functional complexes with -factor binding defective receptors and G 
protein-coupling defective receptors.  I also tested less severe mutants of the affected 
codons C59 and H94.  Two substitution mutations, C59A and H94A, were included in 
this study.  Consistent with earlier studies with full-length Ste2-C59A (David et al., 1997; 
Yesilaltay and Jenness, 2000), I found that truncated Ste2-C59A localizes properly on the 
cell surface and -factor sensitivity is indistinguishable from truncated wild-type Ste2.  
Amino acid C59 is located within the 56GxxxG60 motif.  Substitution of cysteine with a 
bulky charged amino acid such as arginine into the proposed dimer interface may cause a 
steric contact problem between adjoining subunits; also the presence of arginine at 
position 58 may aggravate the presence of arginine in the neighboring position 59.  
However, I cannot rule out the possibility that the C59R substitution leads to a grossly 
misfolded receptor.  Unlike Ste2-C59A-T326, truncated Ste2-H94A-T326 was retained in 
ER.  Apparently, some of the Ste2-H94A and Ste2-H94A-T326 receptors were able to 
reach the plasma membrane in an active form since the mutants showed some (albeit 
reduced) -factor sensitivity.  It is possible that the Ste2-H94A receptor reflects a leaky 
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oligomer mutant; therefore, a small amount of mutant receptors escape the quality control 
machinery in the ER and reach the plasma membrane by forming weak oligomers.  The 
partial function of Ste2-H94A and Ste2-H94A-T326 suggests that they are not grossly 
misfolded.  Further investigation is required to test whether the Ste2-H94A can form 
homo or hetero dimers. 
Most GPCRs appear to form dimers or higher oligomeric complexes.  However, 
the functional significance for dimerization has been built mainly on the requirement for 
intracellular trafficking.  The importance of dimerization on cell-surface targeting was 
implied for several GPCRs such as GABA receptors (Jones et al., 1998; White et al., 
1998), 2-adrenergic receptor (Salahpour et al., 2004) and D2 dopamine receptors (Lee 
et al., 2000).  However, whether oligomerizaton is required for functional coupling to 
heterotrimeric G-proteins remains inconclusive.  Leukotriene B4 receptor (BLT1 
receptor) reconstituted with G-protein with solution-phase neutron-scattering experiments 
suggest that one G-protein binds to a receptor dimer (Baneres and Parello, 2003).  In the 
best-known heterodimeric complex, the GABA receptor complex, GABA b1 and GABA 
b2 are required for proper location and normal function; however, only one subunit 
couples to a G-protein and the other subunit binds the agonist.  The conclusion is based 
on normal receptor heterodimer function when the agonist-binding GABA b1 subunit 
contains a defect in third intracellular loop, whereas the heterodimers are not functional 
when the same third-loop defect affects the agonist-binding-defective GABA b2 subunit 
(Duthey et al., 2002).  For the metabotropic glutamate receptor, upon activation, only one 
heptahelical domain of the homodimer is turned on (Hlavackova et al., 2005).  Recently, 
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it has been speculated that dimerization of GPCRs may play a role in facilitating the 
activation of heterotrimeric G proteins.  In studies of rhodopsin, monomers activate G 
proteins, however, the activation process is faster when the rhodopsin is organized into 
dimers or higher order oligomers (Jastrzebska et al., 2004; Ridge and Palczewski, 2007). 
Two results in this chapter provide suggestive evidence indicating that dimers 
containing two functional receptors are not required for the -factor response.  First, the 
ability of the truncated receptors, Ste2-F204S-T326 and Ste2-S141P-T326, to 
complement is consistent with this view.  Since Ste2-S141P-T326 reaches the plasma 
membrane only when it associates with Ste2-F204S-T326, the only receptor dimers on 
the cell surface that contain an -factor binding site will be heterodimers.  Furthermore, 
since F204S-T326 will not undergo ligand-induced conformational changes and since no 
detectable conformational changes are transduced between subunits (Chapter 3), the 
single Ste2-S141P-T326 receptor is expected to be the only subunit in the heterodimer 
that can reach the activated state.  The second piece of evidence is the -factor sensitivity 
associated with full-length Ste2-S141P.  The observation that full-length Ste2-S141P 
cannot rescue the truncated Ste2-S141P-T326-GFP from the ER, suggests that receptors 
containing the S141P substitution cannot form homodimers.  Therefore, full-length 
Ste2-S141P receptors that reach the cell surface are expected to be in a monomeric state, 
implying that monomers at the cell surface are active.  My results support the view that 
dimerization of two active Ste2 receptors is not required for G-protein coupling and that a 
single monomer of Ste2-S141P is able to activate a G-protein.   
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Recent evidence has shown that rhodopsin can form two-dimensional arrays of 
dimers and a model derived from atomic force microscopy analysis suggested that TM4 
and TM5 were involved in intradimer contact, while TM1, TM2 and TM6 may facilitate 
contacts between dimer rows (Fotiadis et al., 2003; Liang et al., 2003).  So far, rhodopsin 
is the only GPCR that has been clearly demonstrated to form higher-order oligomers 
using atomic force microscopy (AFM) as the analytical method.  Cross-linking studies 
consistent with previous results further refine the model of a rhodopsin and reveal three 
major interfaces contributing to oligomerization (Fotiadis et al., 2006).  The intradimeric 
contact involves two symmetric interactions, each between TM4 from one subunit with 
TM5 from the adjacent subunit, resulting in a two-fold axis of symmetry.  This is the 
most extensive (and presumably the strongest) contact and is supported by in vivo 
crosslinking experiments in COS cells (Kota et al., 2006).  The weakest interaction is the 
row-row contact in which TM1 from one subunit interacts with TM1 in an adjacent 
subunit.   
Results presented in this study indicate that TM1 (C59R), TM2 (H94P) and TM3 
(S141P and S145P) are important for ER export and receptor oligomerization.  My study 
does not exclude the possibility that other TM domains are also involved in ER 
trafficking and formation of oligomeric complexes.  This study also raises the possibility 
that more than one contact site is operating in the oligomerization of Ste2.  It is not 
possible to identify unambiguously which TMs are involved in direct contact since no 
high-resolution crystal structure of Ste2 is available.  Overton et al (2003) showed that 
TM1 could self-associate, suggesting that TM1 may provide the direct contact interface 
  185 
in whole receptors as well.  In this model, mutant receptors affecting TM2 and TM3 may 
fail to form oligomers because they alter the global structure of the Ste2 such that they 
indirectly perturb the intersubunit contact site in the TM1.  However, it seems 
inconsistent with this view that the strongest mutant identified by Overton et al (2003), 
Ste2-G56L, blocks homodimerization only partially, whereas it completely blocks 
receptor function.  In contrast, Ste2-S141P retains receptor function when it reaches the 
plasma membrane, even though it completely blocks homodimer formation.   
Fig. 5-10 depicts a model in which TM3 participates in a direct contact interface.  
In this model, a symmetric axis and two symmetric contacts exist between Ste2 
oligomers.  In each contact, TM3 from one subunit associates with an unidentified site on 
the other subunit, and is analogous to the intradimer interface in rhodopsin involving 
TM4 and TM5.  This model explains why the mutants that disrupt TM3 (Ste2-S141p and 
Ste2-S145P) fail to form homodimers even though they form heterodimers with 
wild-type receptors.  The heterodimers form one of the two contacts present in the 
wild-type homodimer, whereas the mutant homodimers form neither of the two contacts.  
The model also requires that the mutant affects only local structures in that it impairs 
only one of the two contact sites.  Consistent with local disruption, full-length Ste2-
S141p retains its responsiveness to -factor, and the Ste2-S141p and Ste2-S145P 
receptors retain sufficient tertiary structure to interact with wild-type receptors.  
However, if this model reflects the only subunit interface, then other dimer-defective 
mutants (Ste2-G56L, Ste2-C59R and Ste2-H94P) may cause more global structural  
















































predicted to be the direct contact interface, whereas disruption of TM1 or TM2 leads to 
indirect effect.  The two models described above are not mutually exclusive.  It is 
possible that Ste2 oligomerization requires multiple contact interfaces and different 
interfaces function cooperatively.  Therefore, mutation in any one of the interfaces can 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































with the observation that the truncated Ste2-C59A localizes properly on the cell surface, 






Q135 (TMIII) in the model of Eilers et al., (2005).  The H94P substitution is expected to 
cause a kink in the TM2 helix and disrupt the hydrogen-bond with TMI.  My results are 
consistent with the prediction that H94 would serve to stabilize the TMI and TMII 
interaction of the Ste2 (Eilers et al., 2005) Since truncated H94P and H94A both lead to 
ER retention.  In this view, H94P and H94A may be similar to C59R in disrupting contact 
3 (Fig. 6­3A).  Again, I cannot rule out the possibility that substitutions at H94 cause 
global disruptions in receptor structure.   
The Ste2­S141P and Ste2­S145P mutants represent a class of mutant receptors 
that are qualitatively different from Ste2­C59R and Ste2­H94P.  The phenotype does not 
appear to reflect a global disruption of receptor structure since Ste2­S141P and Ste2­
S145P form heterooligomers with wild­type receptors and since the Ste2­S141P and 
Ste2­F55L,S145P receptors that reach the plasma membrane are active.  Both S141 and 
S145 are near the cytoplasmic end of TMIII, the most interior of the seven helices in 
rhodopsin and in the Ste2 model (Eilers et al., 2005).  Therefore, possibility for direct 
contact between TMIII and helices in adjacent receptors is limited.  S141 faces outward 
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in the model of Eilers et al (2005) and is weakly conserved.  S145 is highly conserved 
among Ste2 homologs and is believed to form hydrogen bonds with TMII (Eilers et al., 
2005).  In term of rhodopsin oligomeric structure (Fig. 6­3A), the S141P and S145P 
substitutions could influence TMII or TMVI, indirectly affecting contact 2.  It is also 
possible that the kink in TMIII caused by S141P and S145P could affect cytoplasmic 
loop 2.  Residues in this loop have been implicated in contact 2 (Liang et al., 2003).  As 
discussed previously (Fig. 5­10), the ability of mutant receptors to form hetero­ but not 
homooligomers may be a consequence of redundant symmetric contacts between 
receptors.  Contact 1 (Fig. 6­3A) contains symmetric redundant interactions between 
TMIV and TMV.  Also, two receptor dimers (joined by contact 1 or contact 3) are bound 
by two symmetric and redundant contact 2 sites. 
S141 and S145 have been implicated in receptor structural changes.  Previous 
results showed that S141P is an intragenic suppressor for Ste2­F204S and Ste2­Y266C 
(Lin et al., 2005).  My data also showed the S141P complement Ste2­F204S and Ste2­
L236H mutants by forming hetero­oligomers.  The loss of function in Ste2­S145P can be 
rescued by second mutation F55L (in the original double mutant).  F55L also suppresses 
the G­protein defect in Ste2­Y266C (Lin et al., 2005).  Therefore, F55L may serve as a 
global suppressor in Ste2 by stabilizing the Ste2 structure.  Interestingly, S141P, S145L 
and S145T cause mild agonist­independent activation of the receptor (Lin et al., 2005).  
Therefore, the oligomeric structures that require S141 and S145 may help to constrain the 
unliganded receptor in the inactive conformation.  
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Based on the model of rhodopsin (Fig. 6­3A), different TM domains in Ste2 may 
be involved in different contacts, such as the intradimeric, interdimeric or row–row 
contacts in the higher­order structure.  Together, these interactions may constitute a 
cooperative network that can be broken by single mutations in the STE2 gene.  On the 
one hand, single mutations in STE2 causing global disruption of multiple contacts may 
lead to inability to form higher oligomeric complex.  On the other hand, mutations in 
STE2 causing the local disruption of single receptor contact may disrupt the higher order 
structure by breaking the cooperative network of interactions. 
Several unaddressed questions are discussed below.  First, I did not address 
whether the hetero­oligomer formation between Ste2­T326 and Ste2­S141P­T326 is 
sufficient to promote exit of Ste2­S141P­T­326 from the ER even though coexpression of 
Ste2­S141P­T326 and Ste2­F204S­T326 showed full  ­factor sensitivity, implying that 
Ste2­S141P­T­326 exits from the ER and reaches cell surface.  Second, although Ste2­
G56L still can form homo­oligomers or hetero­oligomers; however, unlike the truncated 
Ste2­T326­GFP, most of Ste2­G56L­T326­GFP accumulated in the vacuole instead of 
remaining on the cell surface (Fig. 5­4 and Fig. 5­5) in the coexpression experiments.  
This result suggests that the Ste2­G56L that escapes the ER is diverted to the vacuole by 
a post­ER quality control process.  It will be of interest to determine whether these 
defective receptors are diverted to the vacuole before reaching the plasma membrane, as 
has been shown for the Ste2­3 temperature­sesitive receptor (Jenness et al., 1997).  It 
would be also be interesting to determine whether trafficking to the plasma membrane 
can be restored by disrupting elements of the post­ER quality control process (Li et al., 
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1997).  Third, my data suggest TMI, II and III are involved directly or indirectly in Ste2 
oligomerization.  It remains unclear whether other domains influence contact interfaces 
as well.  No repeated mutants were recovered in both of my mutant screens, suggesting 
that mutants from both screening methods have not been saturated.  More screening and 
mutants are required to map out the direct dimer contacts between Ste2 subunits.   
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